Marcos Garcia Teneche
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcos Garcia Teneche has a total of 402 co-authors. Here are the top co-authors by number of shared publications:
- Peter D. Adams
Sanford Burnham Prebys Medical Discovery Institute, La Jolla CA
16 shared publications Xue Lei
Cancer Genome and Epigenetics Program; Sanford Burnham Prebys MDI; La Jolla, CA, USA
9 shared publications- Aaron Havas
Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
8 shared publications Adarsh Rajesh
Cancer Genome and Epigenetic Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA
7 shared publicationsAndrew Davis
Cancer Genome and Epigenetics Program; Sanford Burnham Prebys MDI; La Jolla, CA, USA
6 shared publications- April E. Williams
Salk Institute for Biological Studies
5 shared publications
Latest Publications
- Open Access
p53 supports healthy aging
P53 is a master regulator of cellular stress responses that is also implicated in the aging process. Its role in aging is often considered an example of antagonistic pleiotropy (AP), where it acts beneficially as a tumor suppressor early in life, but detrimentally in late life, for example by driving accumulation of stress-associated, pro-inflammatory senescent cells. However, the causal role of p53 in aging is not well-defined, and the AP model has not been definitively tested through loss- of-function studies. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mouse liver by suppressing excessive inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic and spatial profiling at the single-cell level in aged mouse liver confirmed age-dependent increase in p53 pathway activation. Hepatocyte-specific knockout of p53 in livers of aged mice, but not of young mice, increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and DNA damage, known precursors to inflammatory signaling. In aged hepatocytes, p53 also directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Complementing these loss-of-function data, pharmacological activation of p53 with the small-molecule MDM2 inhibitor HDM201 in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation and delayed onset of frailty. These results identify p53 activity in aged tissue as protective rather than degenerative. Importantly, this protective function is pharmacologically targetable, potentially for the benefit of healthy aging in humans.
Open Accessp53 supports healthy aging
P53 is a master regulator of cellular stress responses that is also implicated in the aging process. Its role in aging is often considered an example of antagonistic pleiotropy (AP), where it acts beneficially as a tumor suppressor early in life, but detrimentally in late life, for example by driving accumulation of stress-associated, pro-inflammatory senescent cells. However, the causal role of p53 in aging is not well-defined, and the AP model has not been definitively tested through loss- of-function studies. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mouse liver by suppressing excessive inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic and spatial profiling at the single-cell level in aged mouse liver confirmed age-dependent increase in p53 pathway activation. Hepatocyte-specific knockout of p53 in livers of aged mice, but not of young mice, increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and DNA damage, known precursors to inflammatory signaling. In aged hepatocytes, p53 also directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Complementing these loss-of-function data, pharmacological activation of p53 with the small-molecule MDM2 inhibitor HDM201 in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation and delayed onset of frailty. These results identify p53 activity in aged tissue as protective rather than degenerative. Importantly, this protective function is pharmacologically targetable, potentially for the benefit of healthy aging in humans.
- 14 October 2026
- Published by Springer Nature in Nature Metabolism
- p. 1-19
Genetic modulation of NAD(P)H homeostasis reveals distinct redox-coupled metabolic vulnerabilities
- 14 October 2026
- Published by Springer Nature in Nature Metabolism
- p. 1-19
Genetic modulation of NAD(P)H homeostasis reveals distinct redox-coupled metabolic vulnerabilities
- 20 August 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (9) , 1829-1848
Inhibiting cyclin D1–CDK6 suppresses senescence-associated inflammatory gene expression and age-related functional decline
Cellular senescence contributes to aging and age-related diseases by driving chronic inflammation through the senescence-associated secretory phenotype (SASP), including interferon-stimulated genes (ISGs). Here we confirm and extend previous observations that cyclin D1 (CCND1), a key cell cycle regulator, is paradoxically upregulated across models of nonproliferating senescent cells. We show that CCND1 and its kinase partner CDK6 drive SASP and ISG expression in senescent cells by promoting DNA damage accumulation. This leads to the formation of cytoplasmic chromatin fragments that activate pro-inflammatory cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling. In aged mouse livers, senescent hepatocytes show increased Ccnd1 expression. Hepatocyte-specific Ccnd1 knockout or treatment with the clinical grade CDK4/6 inhibitor palbociclib reduces DNA damage and ISGs in aged mouse liver. Further, palbociclib suppresses frailty and improves physical performance of aged mice. These findings demonstrate a role for CCND1/CDK6 in regulating DNA damage and inflammation in senescence and aging, highlighting it as a promising target for therapeutic repurposing.
- 20 August 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (9) , 1829-1848
Inhibiting cyclin D1–CDK6 suppresses senescence-associated inflammatory gene expression and age-related functional decline
Cellular senescence contributes to aging and age-related diseases by driving chronic inflammation through the senescence-associated secretory phenotype (SASP), including interferon-stimulated genes (ISGs). Here we confirm and extend previous observations that cyclin D1 (CCND1), a key cell cycle regulator, is paradoxically upregulated across models of nonproliferating senescent cells. We show that CCND1 and its kinase partner CDK6 drive SASP and ISG expression in senescent cells by promoting DNA damage accumulation. This leads to the formation of cytoplasmic chromatin fragments that activate pro-inflammatory cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling. In aged mouse livers, senescent hepatocytes show increased Ccnd1 expression. Hepatocyte-specific Ccnd1 knockout or treatment with the clinical grade CDK4/6 inhibitor palbociclib reduces DNA damage and ISGs in aged mouse liver. Further, palbociclib suppresses frailty and improves physical performance of aged mice. These findings demonstrate a role for CCND1/CDK6 in regulating DNA damage and inflammation in senescence and aging, highlighting it as a promising target for therapeutic repurposing.
- Open Access
- 1 June 2026
- Published by Springer Nature in Research Square
HIRA-mediated H3.3 deposition preserves hepatocyte cell identity during liver aging
Age-associated functional decline is partly driven by progressive chromatin degeneration. Maintenance of chromatin integrity preserves cell identity and promotes healthy aging, but through different mechanisms in proliferating and non-proliferating cells. However, specific mechanisms of chromatin maintenance and their compensatory capacity in proliferating and non-proliferating cells are undefined. The histone chaperone HIRA deposits the histone variant H3.3 in a DNA replication-independent manner, leading to its accumulation in aging, non-proliferating cells. Here, we show that hepatocyte-specific loss of HIRA causes loss of cell identity, metabolic dysfunction, and accelerated fibrotic pathology with age. Transcriptomic and epigenomic analyses indicate that HIRA-H3.3 preserves chromatin integrity and sustains transcription of highly expressed genes, including cell identity genes. Partial hepatectomy, associated with induced proliferation, restores identity of HIRA knockout livers with compensatory deposition of canonical histones H3.1/2. Together, these results demonstrate that HIRA-mediated H3.3 deposition is essential for safeguarding cell identity and tissue function during aging of non-proliferating cells, but this function can be rescued by tissue regeneration and associated cell proliferation.
- 1 June 2026
- Published by Springer Nature in Research Square
Open AccessHIRA-mediated H3.3 deposition preserves hepatocyte cell identity during liver aging
Age-associated functional decline is partly driven by progressive chromatin degeneration. Maintenance of chromatin integrity preserves cell identity and promotes healthy aging, but through different mechanisms in proliferating and non-proliferating cells. However, specific mechanisms of chromatin maintenance and their compensatory capacity in proliferating and non-proliferating cells are undefined. The histone chaperone HIRA deposits the histone variant H3.3 in a DNA replication-independent manner, leading to its accumulation in aging, non-proliferating cells. Here, we show that hepatocyte-specific loss of HIRA causes loss of cell identity, metabolic dysfunction, and accelerated fibrotic pathology with age. Transcriptomic and epigenomic analyses indicate that HIRA-H3.3 preserves chromatin integrity and sustains transcription of highly expressed genes, including cell identity genes. Partial hepatectomy, associated with induced proliferation, restores identity of HIRA knockout livers with compensatory deposition of canonical histones H3.1/2. Together, these results demonstrate that HIRA-mediated H3.3 deposition is essential for safeguarding cell identity and tissue function during aging of non-proliferating cells, but this function can be rescued by tissue regeneration and associated cell proliferation.
- Open Access
A Manifold-Based Measure of Transcriptional Entropy for Quantifying Aging in Single Cells
Characterizing cellular aging is essential for understanding age-related diseases. While tissue-level studies reveal broad age-associated changes, they often reflect compositional shifts rather than cell-level reprogramming. The cellular damage hypothesis posits that aging involves the accumulation of DNA, chromatin, and other damage across molecular layers, increasing transcriptional entropy. Existing supervised methods for detecting cellular senescence yield cell type-specific senescence scores but rely on labeled data and lack generalizability. Here, we introduce a first-principles framework for quantifying transcriptional entropy in single cells as each cell's deviation from a transcriptomic manifold, capturing breakdown of transcriptional coordination. This unsupervised approach identifies aging-affected cell types and distinguishes two cellular aging mechanisms: loss of expression precision and activation of stress-response pathways in high entropy cells. Applied to Tabula Muris Senis and SenNet Multiome datasets, transcriptional entropy correlates with chromatin-based mitotic age and highlights regenerative tissue compartments as most affected by aging.
Open AccessA Manifold-Based Measure of Transcriptional Entropy for Quantifying Aging in Single Cells
Characterizing cellular aging is essential for understanding age-related diseases. While tissue-level studies reveal broad age-associated changes, they often reflect compositional shifts rather than cell-level reprogramming. The cellular damage hypothesis posits that aging involves the accumulation of DNA, chromatin, and other damage across molecular layers, increasing transcriptional entropy. Existing supervised methods for detecting cellular senescence yield cell type-specific senescence scores but rely on labeled data and lack generalizability. Here, we introduce a first-principles framework for quantifying transcriptional entropy in single cells as each cell's deviation from a transcriptomic manifold, capturing breakdown of transcriptional coordination. This unsupervised approach identifies aging-affected cell types and distinguishes two cellular aging mechanisms: loss of expression precision and activation of stress-response pathways in high entropy cells. Applied to Tabula Muris Senis and SenNet Multiome datasets, transcriptional entropy correlates with chromatin-based mitotic age and highlights regenerative tissue compartments as most affected by aging.
- Open Access
- 18 November 2025
- Published by Springer Nature in Research Square
Nucleosome stability safeguards cell identity, stress resilience and healthy aging
The Information Theory of Aging (ITOA) proposes that aging results from the progressive loss of epigenetic information. As the repeating units of the epigenome, nucleosomes are considered pivotal for its stability. Accordingly, the ITOA predicts that destabilization of nucleosomes will accelerate aging. However, this causal link has not been directly tested. Here, we addressed this through histone mutants that weaken histone–histone interactions. Without broadly perturbing steady-state chromatin accessibility, DNA damage, cell proliferation or viability, nucleosome instability compromised cell identity maintenance, altered lineage specification and activated intrinsic inflammatory and stress pathways in a manner reminiscent of aging in mouse tissues and human cells. Consistently, nucleosome instability accelerated age-associated transcriptional alterations and functional decline in Caenorhabditis elegans and Drosophila melanogaster, and reduced cellular resilience to exogenous perturbations—including environmental, epigenetic and mitotic stress—in human cells and Saccharomyces cerevisiae. These cross-species findings establish nucleosome stability as a fundamental requirement for preserving cell identity and stress resilience, thereby safeguarding organismal longevity.
- 18 November 2025
- Published by Springer Nature in Research Square
Open AccessNucleosome stability safeguards cell identity, stress resilience and healthy aging
The Information Theory of Aging (ITOA) proposes that aging results from the progressive loss of epigenetic information. As the repeating units of the epigenome, nucleosomes are considered pivotal for its stability. Accordingly, the ITOA predicts that destabilization of nucleosomes will accelerate aging. However, this causal link has not been directly tested. Here, we addressed this through histone mutants that weaken histone–histone interactions. Without broadly perturbing steady-state chromatin accessibility, DNA damage, cell proliferation or viability, nucleosome instability compromised cell identity maintenance, altered lineage specification and activated intrinsic inflammatory and stress pathways in a manner reminiscent of aging in mouse tissues and human cells. Consistently, nucleosome instability accelerated age-associated transcriptional alterations and functional decline in Caenorhabditis elegans and Drosophila melanogaster, and reduced cellular resilience to exogenous perturbations—including environmental, epigenetic and mitotic stress—in human cells and Saccharomyces cerevisiae. These cross-species findings establish nucleosome stability as a fundamental requirement for preserving cell identity and stress resilience, thereby safeguarding organismal longevity.
- 15 September 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (10) , 2381-2394
Advancing biological understanding of cellular senescence with computational multiomics
Cellular senescence is a complex biological process that plays a pathophysiological role in aging and age-related diseases. The biological understanding of senescence at the cellular and tissue levels remains incomplete due to the lack of specific biomarkers as well as the relative rarity of senescent cells, their phenotypic heterogeneity and dynamic features. This Review provides a comprehensive overview of multiomic approaches for the characterization and biological understanding of cellular senescence. The technical capability and challenges of each approach are discussed, and practical guidelines are provided for selecting tools for identifying, characterizing and spatially mapping senescent cells. The importance of computational analyses in multiomics research, including senescent cell identification, signature detection and interactions of senescent cells with microenvironments, is highlighted. Moreover, tissue-specific case studies and experimental design considerations for individual organs are presented. Finally, future directions and the potential impact of multiomic approaches on the biological understanding of cellular senescence are discussed.
- 15 September 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (10) , 2381-2394
Advancing biological understanding of cellular senescence with computational multiomics
Cellular senescence is a complex biological process that plays a pathophysiological role in aging and age-related diseases. The biological understanding of senescence at the cellular and tissue levels remains incomplete due to the lack of specific biomarkers as well as the relative rarity of senescent cells, their phenotypic heterogeneity and dynamic features. This Review provides a comprehensive overview of multiomic approaches for the characterization and biological understanding of cellular senescence. The technical capability and challenges of each approach are discussed, and practical guidelines are provided for selecting tools for identifying, characterizing and spatially mapping senescent cells. The importance of computational analyses in multiomics research, including senescent cell identification, signature detection and interactions of senescent cells with microenvironments, is highlighted. Moreover, tissue-specific case studies and experimental design considerations for individual organs are presented. Finally, future directions and the potential impact of multiomic approaches on the biological understanding of cellular senescence are discussed.
- 10 September 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (2) , 424-439
Efficacious suppression of primary and metastasized liver tumors by polyIC-loaded lipid nanoparticles
Background and Aims: So far, there is no effective mechanism-based therapeutic agent tailored for liver tumors. Immune checkpoint inhibitors (ICIs) have demonstrated limited efficacy in liver cancer, often associated with severe adverse effects. Although poly-inosinic:cytidylic acid (polyIC) has shown an adjuvant effect when combined with anti-PD-L1 antibody (αPD-L1) in treating liver tumors in animal models, its systemic toxicity limits its clinical utility. To address this challenge, the original goal of this study was to develop a liver-targeted strategy to minimize toxicity. Methods and Results: We constructed lipid nanoparticles (LNPs) encapsulating polyIC for selective delivery to the liver and evaluated the tumor-suppressive effects of polyIC-LNPs, free polyIC, and/or αPD-L1 in multiple murine liver tumor models. We also analyzed changes in the hepatic immune microenvironment using single-cell RNA sequencing and flow cytometry. Surprisingly, polyIC-LNPs alone robustly suppressed both primary and metastatic liver tumors, independent of αPD-L1. Even a single dose of polyIC-LNPs was sufficient to control liver tumor progression. Primarily taken up by hepatocytes, polyIC-LNPs induced sustained type I interferon signaling, reshaped the hepatic immune landscape, and promoted CD8⁺ T cell infiltration and activation by enhancing the maturation of conventional dendritic cells (cDC1), ultimately resulting in a potent anti-tumor response. Conclusion: Contrary to our original goal, we unexpectedly found that polyIC-LNPs function as an efficacious monotherapy tailored for liver cancer, capable of coordinately modulating antitumor immunity. This novel approach eliminates the need for ICIs, thereby addressing key limitations of current immunotherapies.
- 10 September 2025
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (2) , 424-439
Efficacious suppression of primary and metastasized liver tumors by polyIC-loaded lipid nanoparticles
Background and Aims: So far, there is no effective mechanism-based therapeutic agent tailored for liver tumors. Immune checkpoint inhibitors (ICIs) have demonstrated limited efficacy in liver cancer, often associated with severe adverse effects. Although poly-inosinic:cytidylic acid (polyIC) has shown an adjuvant effect when combined with anti-PD-L1 antibody (αPD-L1) in treating liver tumors in animal models, its systemic toxicity limits its clinical utility. To address this challenge, the original goal of this study was to develop a liver-targeted strategy to minimize toxicity. Methods and Results: We constructed lipid nanoparticles (LNPs) encapsulating polyIC for selective delivery to the liver and evaluated the tumor-suppressive effects of polyIC-LNPs, free polyIC, and/or αPD-L1 in multiple murine liver tumor models. We also analyzed changes in the hepatic immune microenvironment using single-cell RNA sequencing and flow cytometry. Surprisingly, polyIC-LNPs alone robustly suppressed both primary and metastatic liver tumors, independent of αPD-L1. Even a single dose of polyIC-LNPs was sufficient to control liver tumor progression. Primarily taken up by hepatocytes, polyIC-LNPs induced sustained type I interferon signaling, reshaped the hepatic immune landscape, and promoted CD8⁺ T cell infiltration and activation by enhancing the maturation of conventional dendritic cells (cDC1), ultimately resulting in a potent anti-tumor response. Conclusion: Contrary to our original goal, we unexpectedly found that polyIC-LNPs function as an efficacious monotherapy tailored for liver cancer, capable of coordinately modulating antitumor immunity. This novel approach eliminates the need for ICIs, thereby addressing key limitations of current immunotherapies.
- Open Access
Rapamycin Reverses the Hepatic Response to Diet-Induced Metabolic Stress That Is Amplified by Aging
Aging is associated with increased susceptibility to metabolic stress and chronic liver disease, yet the interactions between age and metabolic stressors and the potential for ameliorating interventions remain incompletely understood. Here, we examined the hepatic response of young (7-month-old) and old (25-month-old) C57BL/6 male mice to a 9-week high-fat diet (HFD) and assessed whether rapamycin, a well-established pro-longevity intervention, could mitigate age-exacerbated effects. While both age groups developed metabolic-associated steatohepatitis (MASH), older mice displayed more severe hepatic steatosis, inflammation, and transcriptional dysregulation. Transcriptomic profiling of whole livers and purified hepatocytes revealed that aging amplifies HFD-induced inflammatory and metabolic gene expression changes, including activation of immune pathways and suppression of metabolic pathways. Notably, treatment of aging mice with rapamycin reversed the majority of HFD-driven transcriptional alterations, including upregulation of pro-inflammatory regulators such as Stat1, and dysregulation of metabolic gene networks. Rapamycin also reduced hepatosteatosis, total body weight, and a tumorigenic transcriptomic signature associated with hepatocellular carcinoma risk. These findings demonstrate that aging intensifies hepatic sensitivity to metabolic stress and identify rapamycin as a promising therapeutic to counteract age-related liver dysfunction and MAFLD progression.
Open AccessRapamycin Reverses the Hepatic Response to Diet-Induced Metabolic Stress That Is Amplified by Aging
Aging is associated with increased susceptibility to metabolic stress and chronic liver disease, yet the interactions between age and metabolic stressors and the potential for ameliorating interventions remain incompletely understood. Here, we examined the hepatic response of young (7-month-old) and old (25-month-old) C57BL/6 male mice to a 9-week high-fat diet (HFD) and assessed whether rapamycin, a well-established pro-longevity intervention, could mitigate age-exacerbated effects. While both age groups developed metabolic-associated steatohepatitis (MASH), older mice displayed more severe hepatic steatosis, inflammation, and transcriptional dysregulation. Transcriptomic profiling of whole livers and purified hepatocytes revealed that aging amplifies HFD-induced inflammatory and metabolic gene expression changes, including activation of immune pathways and suppression of metabolic pathways. Notably, treatment of aging mice with rapamycin reversed the majority of HFD-driven transcriptional alterations, including upregulation of pro-inflammatory regulators such as Stat1, and dysregulation of metabolic gene networks. Rapamycin also reduced hepatosteatosis, total body weight, and a tumorigenic transcriptomic signature associated with hepatocellular carcinoma risk. These findings demonstrate that aging intensifies hepatic sensitivity to metabolic stress and identify rapamycin as a promising therapeutic to counteract age-related liver dysfunction and MAFLD progression.
- Open Access
- 5 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
p53 enhances DNA repair and suppresses cytoplasmic chromatin fragments and inflammation in senescent cells
Genomic instability and inflammation are distinct hallmarks of aging, but the connection between them is poorly understood. Here we report a mechanism directly linking genomic instability and inflammation in senescent cells through a mitochondria-regulated molecular circuit involving p53 and cytoplasmic chromatin fragments (CCF) that are enriched for DNA damage signaling marker γH2A.X. We show that p53 suppresses CCF accumulation and its downstream inflammatory phenotype. p53 activation suppresses CCF formation linked to enhanced DNA repair and genome integrity. Activation of p53 in aged mice by pharmacological inhibition of MDM2 reverses transcriptomic signatures of aging and age-associated accumulation of monocytes and macrophages in liver. Mitochondrial ablation in senescent cells suppresses CCF formation and activates p53 in an ATM-dependent manner, suggesting that mitochondria-dependent formation of γH2A.X + CCF dampens nuclear DNA damage signaling and p53 activity. These data provide evidence for a mitochondria-regulated p53 signaling circuit in senescent cells that controls DNA repair, genome integrity, and senescence- and age-associated inflammation, with relevance to therapeutic targeting of age-associated disease.
- 5 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open Accessp53 enhances DNA repair and suppresses cytoplasmic chromatin fragments and inflammation in senescent cells
Genomic instability and inflammation are distinct hallmarks of aging, but the connection between them is poorly understood. Here we report a mechanism directly linking genomic instability and inflammation in senescent cells through a mitochondria-regulated molecular circuit involving p53 and cytoplasmic chromatin fragments (CCF) that are enriched for DNA damage signaling marker γH2A.X. We show that p53 suppresses CCF accumulation and its downstream inflammatory phenotype. p53 activation suppresses CCF formation linked to enhanced DNA repair and genome integrity. Activation of p53 in aged mice by pharmacological inhibition of MDM2 reverses transcriptomic signatures of aging and age-associated accumulation of monocytes and macrophages in liver. Mitochondrial ablation in senescent cells suppresses CCF formation and activates p53 in an ATM-dependent manner, suggesting that mitochondria-dependent formation of γH2A.X + CCF dampens nuclear DNA damage signaling and p53 activity. These data provide evidence for a mitochondria-regulated p53 signaling circuit in senescent cells that controls DNA repair, genome integrity, and senescence- and age-associated inflammation, with relevance to therapeutic targeting of age-associated disease.